Company profile: Heppe Medical Chitosan
1.1 - Company Overview
Company description
- Provider of pure biopolymers and nanoparticles based on chitin and chitosan for cosmetic and pharmaceutical applications, offering GMP chitosan and chitosan derivatives; microfluidics for chitosan-TPP nanoparticles for drug delivery; 3D bioprinted chitosan networks for dental use; cisplatin-chitosan microparticles for breast implants; and biodegradable antibacterial chitosan-based masks.
Products and services
- Chitosan Derivatives: Custom-engineered, GMP-grade modified chitosans based on chitin, tailored for specific pharmaceutical and cosmetic applications, supplying pure biopolymer variants with application-specific properties
- Microfluidics for the Production of Chitosan-TPP Nanoparticles: Microfluidic-scale method that precisely controls chitosan-TPP nanoparticle properties for drug delivery, enabling property control for pharmaceutical applications
- GMP Chitosan: GMP-compliant, high-purity chitosan biopolymer produced under Good Manufacturing Practice conditions for use in pharmaceutical and cosmetic applications, supplying pure material based on chitin.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Heppe Medical Chitosan
BioServ
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in upstream production and downstream processing of antibodies and other proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioServ company profile →
Definigen
HQ: United Kingdom
Website
- Description: Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Definigen company profile →
NorthStar Medical Radioisotopes
HQ: United States
Website
- Description: Provider of radioisotopes and radiopharmaceutical CDMO/CMO services for the nuclear medicine market, producing Actinium-225 (Ac-225) and Copper-67 (Cu-67) in scalable, commercial quantities via electron beam accelerators, and delivering end-to-end contract development and manufacturing from research to commercialization, with environmentally friendly accelerator-based production of multiple isotopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthStar Medical Radioisotopes company profile →
G-CON
HQ: United States
Website
- Description: Provider of off-site, prefabricated cleanroom units (PODs) for pharmaceutical development and manufacturing, including design, construction, installation and qualification, enabling faster deployment versus traditional cleanroom infrastructure to address rapidly changing requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full G-CON company profile →
OptraScan
HQ: United States
Website
- Description: Provider of digital pathology slide scanners and imaging solutions that convert glass slides into high-resolution images, with integrated software for image management and telepathology. Offerings include high-speed whole slide scanners, compact low-volume and 15-slide brightfield systems, an AI-enabled cytology scanner with real-time analysis, and a frozen section scanner with live remote review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OptraScan company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Heppe Medical Chitosan
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Heppe Medical Chitosan
2.2 - Growth funds investing in similar companies to Heppe Medical Chitosan
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Heppe Medical Chitosan
4.2 - Public trading comparable groups for Heppe Medical Chitosan
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →